Tempus Labs (United States)
In research, Tempus Labs (United States) stands highest in Medicine (#6,706 of 10,443 worldwide), Health Sciences (#8,014 of 11,982 worldwide) and Life Sciences (#6,470 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research, Oncology and Pulmonary and Respiratory Medicine — Cancer Research is 29.5× its share of world research.
- World rank, 2022–2025
- #11,418 of 28,054 · #18,873 all time
- Rank in United States
- #1,560 of 4,192
- Research works
- 355 ▲ 737% vs 2013–17
- Citations
- 4.3k 12.2 per fractional work
- Top-10% rate
- 10.0% record average 16.5%
- Open access
- 40% world 28%
What is Tempus Labs (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #6,706 of 10,443 | 9.8% | 96 | #11563 | |
| Health SciencesDomain | #8,014 of 11,982 | 9.8% | 100 | #14197 | |
| Life SciencesDomain | #6,470 of 7,800 | 8.7% | 63 | — |
Each strip is that field’s whole ranked pool, with the notch where Tempus Labs (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Tempus Labs (United States) specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 29.5× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 24.1 works30×
- OncologySubfield · 27.1 works13×
- Pulmonary and Respiratory MedicineSubfield · 24.2 works8.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.6×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.6×
- Immunology and Microbiology 2.7×
- Medicine 2.7×
- Physics and Astronomy 1.8×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Health Professions 0.7×
- Economics, Econometrics and Finance 0.5×
- Computer Science 0.5×
- Arts and Humanities 0.3×
- Decision Sciences 0.3×
- Engineering 0.1×
- Mathematics 0.1×
- Environmental Science 0.1×
- Dentistry 0.1×
- Materials Science 0.1×
- Nursing 0.1×
- Chemistry 0.0×
- Agricultural and Biological Sciences 0.0×
- Neuroscience 0.0×
- Psychology 0.0×
- Social Sciences 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Tempus Labs (United States)?
Ranked on the composite score, Kyle A. Beauchamp and Rotem Ben‐Shachar lead among researchers whose main affiliation is Tempus Labs (United States).
- 1 Kyle A. Beauchamp United States · #673,098 worldwide 43 citations · 18 works
- 2 Rotem Ben‐Shachar United States · #1,449,121 worldwide 3 citations · 15 works
Which keywords describe research at Tempus Labs (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Genomic Instability, Cell-Free DNA, Cancer Genomics, Mutational Signatures, Precision Medicine, Chemotherapy and Clinical Trials.
- Fluorouracil
- Reference Genes
- Radiotherapy
- Normalization
- Cetuximab
- Biomarkers
- Quantitative
- Immune Checkpoint Blockade
- Molecular Characterization
- Radiomics
- Prognostic Factors
- ALK Inhibitors
- Medical Imaging
- Predictive Modeling
- Immunotherapy
- Tumor Microenvironment
- Machine Learning
- Precision Medicine
- Cancer Genomics
- Genomic Instability
- Targeted Therapy
- Cell-Free DNA
- Mutational Signatures
- Chemotherapy
- Clinical Trials
- Gene Expression
- Genomic Profiling
- Cancer
- Treatment Guidelines
- EGFR Mutations
- Quantitative Analysis
- Texture Analysis
- Breast Cancer
- PD-1 and PD-L1
- Data Analysis
- Cancer Risk
- Genetic Testing
- Molecular Subtypes
- Real-Time PCR
- BRAF Mutation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Targeted Therapy32▲ 76×4 topics
- Genomic Instability23▲ 109×3 topics
- Cell-Free DNA21▲ 116×2 topics
- Cancer Genomics21▲ 157×1 topic
- Mutational Signatures21▲ 157×1 topic
- Precision Medicine20▲ 23×7 topics
- Chemotherapy19▲ 14×16 topics
- Machine Learning16▲ 2.5×13 topics
- Clinical Trials15▲ 12×10 topics
- Tumor Microenvironment12▲ 15×8 topics
- Gene Expression12▲ 11×7 topics
- Immunotherapy12▲ 8.9×11 topics
- Genomic Profiling11▲ 57×2 topics
- Predictive Modeling11▲ 21×2 topics
- Cancer10▲ 4.0×24 topics
- Medical Imaging10▲ 10×4 topics
- Treatment Guidelines8▲ 21×2 topics
- ALK Inhibitors8▲ 70×1 topic
- EGFR Mutations8▲ 70×1 topic
- Prognostic Factors8▲ 9.8×10 topics
- Quantitative Analysis8▲ 20×1 topic
- Radiomics8▲ 35×1 topic
- Texture Analysis8▲ 18×2 topics
- Molecular Characterization8▲ 23×4 topics
- Breast Cancer7▲ 15×8 topics
- Immune Checkpoint Blockade7▲ 32×1 topic
- PD-1 and PD-L17▲ 32×1 topic
- Quantitative6▲ 38×2 topics
- Data Analysis6▲ 12×3 topics
- Biomarkers6▲ 4.7×8 topics
- Cancer Risk6▲ 15×5 topics
- Cetuximab6▲ 38×2 topics
- Genetic Testing6▲ 28×3 topics
- Normalization6▲ 63×2 topics
- Molecular Subtypes6▲ 37×2 topics
- Radiotherapy6▲ 7.9×8 topics
- Real-Time PCR6▲ 109×1 topic
- Reference Genes6▲ 109×1 topic
- BRAF Mutation5▲ 36×2 topics
- Fluorouracil5▲ 80×1 topic
Which research topics does Tempus Labs (United States) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Radiomics and Machine Learning in Medical Imaging and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 21 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 8 works
- 3 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 8 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 7 works
- 5 Molecular Biology Techniques and Applications Molecular Biology 6 works
- 6 Colorectal Cancer Treatments and Studies Oncology 5 works
- 7 Genetic factors in colorectal cancer Pathology and Forensic Medicine 4 works
- 8 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 3 works
- 9 Machine Learning in Healthcare Artificial Intelligence 3 works
- 10 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tempus Labs (United States)'s research output changed?
Output in 2018–2022 was 737% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Chicago
- University of Chicago
- University of Illinois Chicago
- Loyola University Chicago
- Rush University Medical Center
- Illinois Institute of Technology
- DePaul University
- Experimental Station
- Boeing (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.